US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Phasebio Pharmaceuticals Inc

0.0701

0.0000

Volume:- -

Turnover:- -

Market Cap:3.50M

PE:-0.03

High:0.0701

Open:0.0701

Low:0.0701

Close:0.0701

52wk High:1.38

52wk Low:0.0665

Shares:49.86M

Float Shares:34.41M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1189

EPS(LYR):-2.9844

ROE:-3091.02%

ROA:-106.07%

PB:-0.03

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

8-K - Current report

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PHAS/filings?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHAS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHAS\",,,,,undefined,":{"symbol":"PHAS","market":"US","secType":"STK","nameCN":"Phasebio Pharmaceuticals Inc","latestPrice":0.0701,"timestamp":1683316800000,"preClose":0.0701,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":34410934,"shares":49858116,"eps":-2.118926,"marketStatus":"Post-Mkt","change":0,"latestTime":"05-04 17:28:26 EDT","open":0.0701,"high":0.0701,"low":0.0701,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.118926,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1777939200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1539835200000,"exchange":"NASDAQ","adjPreClose":0.0701,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHAS\",,,,,undefined,":{"symbol":"PHAS","floatShares":34410934,"roa":"-106.07%","roe":"-3091.02%","lyrEps":-2.98438,"shares":49858116,"dividePrice":0,"high":0.0701,"amplitude":0,"preClose":0.0701,"low":0.0701,"week52Low":0.0665,"pbRate":"-0.03","psRate":"4.27","week52High":1.38,"institutionHeld":0,"latestPrice":0.0701,"eps":-2.118926,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.118926,"open":0.0701,"prevYearClose":0.0701},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHAS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-11-03","symbol":"PHAS","reason":null,"defaultRemindTime":1667482200000,"announcedDate":"2022-11-02","type":"delisting","dateTimestamp":1667448000000},{"market":"US","date":"2022-08-12","symbol":"PHAS","fiscalQuarterEnding":"2022/06","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660276800000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2022-05-16","symbol":"PHAS","fiscalQuarterEnding":"2022/03","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1652673600000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2022-03-24","symbol":"PHAS","fiscalQuarterEnding":"2021/12","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1648094400000,"reportTimeType":"post","actualEps":-0.9},{"market":"US","date":"2021-08-12","symbol":"PHAS","fiscalQuarterEnding":"2021/06","expectedEps":-0.6,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHAS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHAS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHAS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHAS","date":"2022-11-03","current":-0.033083,"percent":1,"low":-40.179838,"twenty":-8.368819,"median":-1.659681,"eighty":-0.922494,"high":-0.033985,"avg":-5.857422,"sd":8.285056,"marketCap":3495053},"quantilePoints":[{"date":"2021-05-07","current":-1.313554,"twenty":-12.929433,"median":-5.930307,"eighty":-1.575287,"marketCap":129470489},{"date":"2021-05-14","current":-1.209405,"twenty":-12.908779,"median":-5.789905,"eighty":-1.569613,"marketCap":134265692},{"date":"2021-05-21","current":-1.421051,"twenty":-12.908779,"median":-5.602702,"eighty":-1.562756,"marketCap":157762188},{"date":"2021-05-28","current":-1.472882,"twenty":-12.908779,"median":-5.33527,"eighty":-1.556857,"marketCap":163516432},{"date":"2021-06-04","current":-1.524714,"twenty":-12.908779,"median":-5.121325,"eighty":-1.552605,"marketCap":169270676},{"date":"2021-06-11","current":-1.615419,"twenty":-12.908779,"median":-4.800406,"eighty":-1.552605,"marketCap":179340603},{"date":"2021-06-18","current":-1.719082,"twenty":-12.908779,"median":-4.633261,"eighty":-1.554227,"marketCap":190849091},{"date":"2021-06-25","current":-1.598142,"twenty":-12.908779,"median":-4.619889,"eighty":-1.555936,"marketCap":177422522},{"date":"2021-07-02","current":-1.576545,"twenty":-12.792231,"median":-4.539659,"eighty":-1.556909,"marketCap":175024920},{"date":"2021-07-09","current":-1.580865,"twenty":-12.541431,"median":-4.499545,"eighty":-1.556857,"marketCap":175504440},{"date":"2021-07-16","current":-1.529033,"twenty":-12.185729,"median":-4.479487,"eighty":-1.556857,"marketCap":169750196},{"date":"2021-07-23","current":-1.662931,"twenty":-11.80819,"median":-4.405944,"eighty":-1.556857,"marketCap":184615327},{"date":"2021-07-30","current":-1.55063,"twenty":-11.090829,"median":-4.359143,"eighty":-1.552605,"marketCap":172147798},{"date":"2021-08-06","current":-1.477201,"twenty":-10.941854,"median":-4.339085,"eighty":-1.55063,"marketCap":163995952},{"date":"2021-08-13","current":-1.421051,"twenty":-10.90997,"median":-4.292285,"eighty":-1.539774,"marketCap":157762188},{"date":"2021-08-20","current":-1.352278,"twenty":-10.805841,"median":-4.225427,"eighty":-1.537672,"marketCap":150853396},{"date":"2021-08-27","current":-1.455637,"twenty":-10.620996,"median":-4.131826,"eighty":-1.52844,"marketCap":162383592},{"date":"2021-09-03","current":-1.429797,"twenty":-10.486991,"median":-3.964681,"eighty":-1.526023,"marketCap":159501043},{"date":"2021-09-10","current":-1.347972,"twenty":-10.405124,"median":-3.857708,"eighty":-1.523388,"marketCap":150372971},{"date":"2021-09-17","current":-1.257533,"twenty":-10.330726,"median":-3.804221,"eighty":-1.521374,"marketCap":140284050},{"date":"2021-09-24","current":-1.317825,"twenty":-10.277584,"median":-3.694445,"eighty":-1.516913,"marketCap":147009997},{"date":"2021-10-01","current":-1.339358,"twenty":-10.160673,"median":-3.607939,"eighty":-1.51512,"marketCap":149412122},{"date":"2021-10-08","current":-1.46425,"twenty":-10.096903,"median":-3.555432,"eighty":-1.509388,"marketCap":163344442},{"date":"2021-10-15","current":-1.726954,"twenty":-10.065018,"median":-3.439274,"eighty":-1.511471,"marketCap":192650356},{"date":"2021-10-22","current":-1.709728,"twenty":-9.995934,"median":-3.313638,"eighty":-1.512238,"marketCap":190728657},{"date":"2021-10-29","current":-1.658048,"twenty":-9.964049,"median":-3.206151,"eighty":-1.513302,"marketCap":184963559},{"date":"2021-11-05","current":-1.714034,"twenty":-9.964049,"median":-3.132447,"eighty":-1.51512,"marketCap":191209082},{"date":"2021-11-12","current":-1.503625,"twenty":-9.958924,"median":-3.120163,"eighty":-1.512238,"marketCap":177932937},{"date":"2021-11-19","current":-0.959069,"twenty":-9.928747,"median":-3.104808,"eighty":-1.503586,"marketCap":113492359},{"date":"2021-11-26","current":-0.922494,"twenty":-9.900279,"median":-3.08331,"eighty":-1.499067,"marketCap":109164261},{"date":"2021-12-03","current":-0.808706,"twenty":-9.86308,"median":-3.064884,"eighty":-1.495549,"marketCap":95699066},{"date":"2021-12-10","current":-0.934686,"twenty":-9.829969,"median":-3.028032,"eighty":-1.490266,"marketCap":110606960},{"date":"2021-12-17","current":-0.898111,"twenty":-9.797471,"median":-2.985038,"eighty":-1.478809,"marketCap":106278862},{"date":"2021-12-23","current":-1.032218,"twenty":-9.751483,"median":-2.955283,"eighty":-1.475355,"marketCap":122148556},{"date":"2021-12-31","current":-1.064729,"twenty":-9.740855,"median":-2.948067,"eighty":-1.471055,"marketCap":125995755},{"date":"2022-01-07","current":-0.97126,"twenty":-9.698341,"median":-2.933283,"eighty":-1.469328,"marketCap":114935059},{"date":"2022-01-14","current":-0.906239,"twenty":-9.682399,"median":-2.905191,"eighty":-1.46355,"marketCap":107240662},{"date":"2022-01-21","current":-0.889983,"twenty":-9.618629,"median":-2.899049,"eighty":-1.459924,"marketCap":105317062},{"date":"2022-01-28","current":-0.768068,"twenty":-9.578314,"median":-2.881951,"eighty":-1.45133,"marketCap":90890067},{"date":"2022-02-04","current":-0.727429,"twenty":-9.565487,"median":-2.862197,"eighty":-1.438328,"marketCap":86081069},{"date":"2022-02-11","current":-0.678663,"twenty":-9.529604,"median":-2.825344,"eighty":-1.436465,"marketCap":80310271},{"date":"2022-02-18","current":-0.560811,"twenty":-9.432633,"median":-2.823285,"eighty":-1.429797,"marketCap":66364176},{"date":"2022-02-25","current":-0.459215,"twenty":-9.347607,"median":-2.818173,"eighty":-1.421593,"marketCap":54341680},{"date":"2022-03-04","current":-0.430768,"twenty":-9.283836,"median":-2.806918,"eighty":-1.421051,"marketCap":50975381},{"date":"2022-03-11","current":-0.438896,"twenty":-9.251951,"median":-2.794293,"eighty":-1.414307,"marketCap":51937181},{"date":"2022-03-18","current":-0.44296,"twenty":-9.246637,"median":-2.74262,"eighty":-1.410031,"marketCap":52418081},{"date":"2022-03-25","current":-0.487662,"twenty":-9.231665,"median":-2.730583,"eighty":-1.403231,"marketCap":57707979},{"date":"2022-04-01","current":-0.490357,"twenty":-9.200381,"median":-2.72062,"eighty":-1.399651,"marketCap":64271578},{"date":"2022-04-08","current":-0.482927,"twenty":-9.121658,"median":-2.705574,"eighty":-1.395344,"marketCap":63297767},{"date":"2022-04-14","current":-0.564653,"twenty":-9.089071,"median":-2.677935,"eighty":-1.38853,"marketCap":74009696},{"date":"2022-04-22","current":-0.479212,"twenty":-9.059663,"median":-2.628798,"eighty":-1.381641,"marketCap":62810861},{"date":"2022-04-29","current":-0.408631,"twenty":-9.039066,"median":-2.616514,"eighty":-1.363866,"marketCap":53559649},{"date":"2022-05-06","current":-0.408631,"twenty":-8.990667,"median":-2.598088,"eighty":-1.358918,"marketCap":53559649},{"date":"2022-05-13","current":-0.375197,"twenty":-8.951083,"median":-2.52717,"eighty":-1.352278,"marketCap":49177495},{"date":"2022-05-20","current":-0.356911,"twenty":-8.912042,"median":-2.487531,"eighty":-1.350109,"marketCap":40992607},{"date":"2022-05-27","current":-0.325327,"twenty":-8.817317,"median":-2.466034,"eighty":-1.34139,"marketCap":37365158},{"date":"2022-06-03","current":-0.325497,"twenty":-8.768363,"median":-2.416292,"eighty":-1.337209,"marketCap":37384635},{"date":"2022-06-10","current":-0.314305,"twenty":-8.767628,"median":-2.229295,"eighty":-1.323855,"marketCap":36099203},{"date":"2022-06-17","current":-0.219513,"twenty":-8.760601,"median":-2.12663,"eighty":-1.318299,"marketCap":25211987},{"date":"2022-06-24","current":-0.27666,"twenty":-8.744416,"median":-1.942875,"eighty":-1.313764,"marketCap":31775479},{"date":"2022-07-01","current":-0.254318,"twenty":-8.693539,"median":-1.820295,"eighty":-1.304905,"marketCap":29209484},{"date":"2022-07-08","current":-0.381541,"twenty":-8.606811,"median":-1.798351,"eighty":-1.296292,"marketCap":43821531},{"date":"2022-07-15","current":-0.398541,"twenty":-8.589065,"median":-1.786223,"eighty":-1.287478,"marketCap":45774023},{"date":"2022-07-22","current":-0.449371,"twenty":-8.582367,"median":-1.74445,"eighty":-1.261839,"marketCap":51612025},{"date":"2022-07-29","current":-0.496004,"twenty":-8.511026,"median":-1.742862,"eighty":-1.243959,"marketCap":56967990},{"date":"2022-08-05","current":-0.525679,"twenty":-8.502655,"median":-1.731065,"eighty":-1.222453,"marketCap":60376331},{"date":"2022-08-19","current":-0.547838,"twenty":-8.502655,"median":-1.726604,"eighty":-1.205447,"marketCap":56339671},{"date":"2022-08-22","current":-0.547838,"twenty":-8.502655,"median":-1.724626,"eighty":-1.203824,"marketCap":56339671},{"date":"2022-08-31","current":-0.504205,"twenty":-8.502655,"median":-1.722647,"eighty":-1.187278,"marketCap":51852440},{"date":"2022-09-06","current":-0.528446,"twenty":-8.502655,"median":-1.722395,"eighty":-1.168627,"marketCap":54345346},{"date":"2022-09-16","current":-0.518749,"twenty":-8.486712,"median":-1.718382,"eighty":-1.085861,"marketCap":53348184},{"date":"2022-09-23","current":-0.413594,"twenty":-8.457391,"median":-1.711881,"eighty":-1.062291,"marketCap":42533958},{"date":"2022-09-30","current":-0.092114,"twenty":-8.429351,"median":-1.705421,"eighty":-1.035469,"marketCap":9473042},{"date":"2022-10-07","current":-0.093714,"twenty":-8.426788,"median":-1.693142,"eighty":-1.013525,"marketCap":9637573},{"date":"2022-10-14","current":-0.097447,"twenty":-8.411145,"median":-1.680209,"eighty":-0.968822,"marketCap":10021481},{"date":"2022-10-21","current":-0.095799,"twenty":-8.38399,"median":-1.673202,"eighty":-0.959069,"marketCap":9851963},{"date":"2022-10-28","current":-0.063898,"twenty":-8.369801,"median":-1.662931,"eighty":-0.925745,"marketCap":6571299},{"date":"2022-11-03","current":-0.033985,"twenty":-8.368819,"median":-1.659681,"eighty":-0.922494,"marketCap":3495053}],"updateTime":1777905432589},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"PHAS\",pageSize:20,pageCount:4,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"12192401","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924521000024-PHAS","pdf_url":null,"pub_time":1615737600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"PHAS","title":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/0001169245-21-000024-index.htm","us_notice_code":"Form 10-K","us_title_en":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231.htm","primary":true,"translateUrl":null,"linkName":"phas-20201231.htm","type":"10-K","id":"NTFILECG2A2VfDzXzc7aqr","market":"us","size":1888360},{"description":"EX-10.3","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/ex103-phas10xk2020.htm","primary":false,"translateUrl":null,"linkName":"ex103-phas10xk2020.htm","type":"EX-10.3","id":"NTFILE8sAsJL9J5m5SAH3m","market":"us","size":14559},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/ex231-10xk2020.htm","primary":false,"translateUrl":null,"linkName":"ex231-10xk2020.htm","type":"EX-23.1","id":"NTFILEC8d1LJF6L7mxCx9h","market":"us","size":3367},{"description":"EX-31.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/ex311-phas10xk2020.htm","primary":false,"translateUrl":null,"linkName":"ex311-phas10xk2020.htm","type":"EX-31.1","id":"NTFILE2xUPFjTL2uekuokM","market":"us","size":10201},{"description":"EX-31.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/ex312-phas10xk2020.htm","primary":false,"translateUrl":null,"linkName":"ex312-phas10xk2020.htm","type":"EX-31.2","id":"NTFILEFfyqNoNP5V2NXcji","market":"us","size":10192},{"description":"EX-32.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/ex-321xphas10xk2020.htm","primary":false,"translateUrl":null,"linkName":"ex-321xphas10xk2020.htm","type":"EX-32.1","id":"NTFILE4jpbefR7zPfBgCu7","market":"us","size":5481},{"description":"EX-32.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/ex-322xphas10xk2020.htm","primary":false,"translateUrl":null,"linkName":"ex-322xphas10xk2020.htm","type":"EX-32.2","id":"NTFILEky5EFiTx3BhCHSJJ","market":"us","size":5476},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231_g1.jpg","primary":false,"translateUrl":null,"linkName":"phas-20201231_g1.jpg","type":"GRAPHIC","id":"NTFILEDwtJfb2yJF9AuHmY","market":"us","size":99194},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231_g2.jpg","primary":false,"translateUrl":null,"linkName":"phas-20201231_g2.jpg","type":"GRAPHIC","id":"NTFILEYRwxLyQ64THVjVdi","market":"us","size":34333},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231_g3.jpg","primary":false,"translateUrl":null,"linkName":"phas-20201231_g3.jpg","type":"GRAPHIC","id":"NTFILE13bMfo5tMSCXRLnE","market":"us","size":37112},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231_g4.jpg","primary":false,"translateUrl":null,"linkName":"phas-20201231_g4.jpg","type":"GRAPHIC","id":"NTFILEC3TPPY5MwKmS9Jkn","market":"us","size":34740},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231_g5.jpg","primary":false,"translateUrl":null,"linkName":"phas-20201231_g5.jpg","type":"GRAPHIC","id":"NTFILE8qSxJeWQE1gf6Y6T","market":"us","size":40364},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000024/phas-20201231_g6.jpg","primary":false,"translateUrl":null,"linkName":"phas-20201231_g6.jpg","type":"GRAPHIC","id":"NTFILE37cKBghoqM94AkhW","market":"us","size":31795}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2021-03-15 00:00","pubTimestamp":1615737600,"title_zh":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12155603","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924521000020-PHAS","pdf_url":null,"pub_time":1615392000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000020/0001169245-21-000020-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000020/ex991-31121.htm","primary":true,"translateUrl":null,"linkName":"ex991-31121.htm","type":"EX-99.1","id":"NTFILEFgKdYQHeBvJ5yV4j","market":"us","size":20837},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000020/a8-kx31121.htm","primary":false,"translateUrl":null,"linkName":"a8-kx31121.htm","type":"8-K","id":"NTFILE9PwekTMCMyjP98n3","market":"us","size":34311},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000020/bvlogo1.jpg","primary":false,"translateUrl":null,"linkName":"bvlogo1.jpg","type":"GRAPHIC","id":"NTFILE9jBM3s1P5PNjoXX8","market":"us","size":8467},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000020/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILEDDqkP9buynMFrdo9","market":"us","size":27705}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2021-03-11 00:00","pubTimestamp":1615392000,"title_zh":"8-K  - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12155604","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266121000755-PHAS","pdf_url":null,"pub_time":1613404800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","symbol":"PHAS","title":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000117266121000755/0001172661-21-000755-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000117266121000755/rocksprings-phas123120a1.htm","primary":true,"translateUrl":null,"linkName":"rocksprings-phas123120a1.htm","type":"SC 13G/A","id":"NTFILEFPXzxaQZzshxJBsa","market":"us","size":108180}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2021-02-16 00:00","pubTimestamp":1613404800,"title_zh":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12155599","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924521000004-PHAS","pdf_url":null,"pub_time":1611763200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000004/0001169245-21-000004-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000004/ex991-12821.htm","primary":true,"translateUrl":null,"linkName":"ex991-12821.htm","type":"EX-99.1","id":"NTFILEAju1CLkE4bUqHnDm","market":"us","size":20048},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000004/a8-kx12821.htm","primary":false,"translateUrl":null,"linkName":"a8-kx12821.htm","type":"8-K","id":"NTFILE4DzVe6K1rCoZS2Hg","market":"us","size":24016},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000004/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILE2rZSDNCitJfjJXGB","market":"us","size":27705},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000004/reverseitlogo1.jpg","primary":false,"translateUrl":null,"linkName":"reverseitlogo1.jpg","type":"GRAPHIC","id":"NTFILEDnLQF2vhJmNp4YHa","market":"us","size":45254}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2021-01-28 00:00","pubTimestamp":1611763200,"title_zh":"8-K  - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"11613236","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924521000002-PHAS","pdf_url":null,"pub_time":1611676800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000002/0001169245-21-000002-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000002/ex991-12721.htm","primary":true,"translateUrl":null,"linkName":"ex991-12721.htm","type":"EX-99.1","id":"NTFILEDrQrrhTLNTTya1oT","market":"us","size":15771},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000002/a8-kx12721.htm","primary":false,"translateUrl":null,"linkName":"a8-kx12721.htm","type":"8-K","id":"NTFILE2neNow6LUSD7W4dE","market":"us","size":24039},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000002/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILE4bwNLBwK8fQjJdhF","market":"us","size":27705}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2021-01-27 00:00","pubTimestamp":1611676800,"title_zh":"8-K  - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"11429626","market":"us","labels":[],"media":"sec.gov","original_id":"AN90221921000011-PHAS","pdf_url":null,"pub_time":1610294400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","symbol":"PHAS","title":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000090221921000011/0000902219-21-000011-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SEC SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/902219/000090221921000011/SEC13G_Filing.htm","primary":true,"translateUrl":null,"linkName":"SEC13G_Filing.htm","type":"SC 13G/A","id":"NTFILE9poVVsCsfkcGyGtC","market":"us","size":35479}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2021-01-11 00:00","pubTimestamp":1610294400,"title_zh":"SC 13G/A [Amend]  - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10854598","market":"us","labels":[],"media":"sec.gov","original_id":"AN117266120002338-PHAS","pdf_url":null,"pub_time":1605456000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G  - Statement of acquisition of beneficial ownership by individuals","symbol":"PHAS","title":"SC 13G  - Statement of acquisition of beneficial ownership by individuals","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000117266120002338/0001172661-20-002338-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G  - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000117266120002338/rocksprings-phas110620.htm","primary":true,"translateUrl":null,"linkName":"rocksprings-phas110620.htm","type":"SC 13G","id":"NTFILEijcEo6pQxemrxMKF","market":"us","size":108294}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2020-11-16 00:00","pubTimestamp":1605456000,"title_zh":"SC 13G  - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10820275","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000091-PHAS","pdf_url":null,"pub_time":1605110400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"PHAS","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/0001169245-20-000091-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/phas-20200930.htm","primary":true,"translateUrl":null,"linkName":"phas-20200930.htm","type":"10-Q","id":"NTFILEG8syhBsWSaNAhKP2","market":"us","size":1519403},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/ex311-phas10xq2020q3.htm","primary":false,"translateUrl":null,"linkName":"ex311-phas10xq2020q3.htm","type":"EX-31.1","id":"NTFILEGG3MzoYNVgb3Dct9","market":"us","size":10209},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/ex312-phas10xq2020q3.htm","primary":false,"translateUrl":null,"linkName":"ex312-phas10xq2020q3.htm","type":"EX-31.2","id":"NTFILEBZvTtq9T6Su3JLAF","market":"us","size":10200},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/ex-321xphas10xq2020q3.htm","primary":false,"translateUrl":null,"linkName":"ex-321xphas10xq2020q3.htm","type":"EX-32.1","id":"NTFILE5WkHXzNWV82a3eE1","market":"us","size":4708},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/ex-322xphas10xq2020q3.htm","primary":false,"translateUrl":null,"linkName":"ex-322xphas10xq2020q3.htm","type":"EX-32.2","id":"NTFILE5jNzbSAuiYiAy29e","market":"us","size":4702}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[{"id":58849,"name":"CONDENSED BALANCE SHEETS","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":58850,"name":"CONDENSED BALANCE SHEETS (Parenthetical)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":58851,"name":"CONDENSED STATEMENTS OF OPERATIONS","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":58852,"name":"CONDENSED STATEMENTS OF STOCKHOLDERS??? EQUITY","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":58853,"name":"CONDENSED STATEMENTS OF CASH FLOWS","name_zh":"简明现金流量表","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000091/R6.htm","cdn_url":"https://static.tigerbbs.com/64568480cc6a3873f2a305314287c62c","translation_url":"https://static.tigerbbs.com/ed33deeac2af019f6d8bd3d2f42348ce","translate_status":1}],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2020-11-12 00:00","pubTimestamp":1605110400,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10820116","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000090-PHAS","pdf_url":null,"pub_time":1605110400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/0001169245-20-000090-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/ex991-earningsreleaseq.htm","primary":true,"translateUrl":null,"linkName":"ex991-earningsreleaseq.htm","type":"EX-99.1","id":"NTFILEXSriqobiS9WRjqdS","market":"us","size":67122},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/axearningsreleaseq32020.htm","primary":false,"translateUrl":null,"linkName":"axearningsreleaseq32020.htm","type":"8-K","id":"NTFILEBhm1Rqs8Ly3N3ws5","market":"us","size":28105},{"description":"EX-99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie.htm","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie.htm","type":"EX-99.2","id":"NTFILE37jQLzPxQo1bb24Q","market":"us","size":56242},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILE8u44Sk7T3ksky8yY","market":"us","size":27705},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie001.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie001.jpg","type":"GRAPHIC","id":"NTFILEBYKkhtahPP3kc1aZ","market":"us","size":65031},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie002.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie002.jpg","type":"GRAPHIC","id":"NTFILEFZUyZQpxuqEmSBgZ","market":"us","size":201484},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie003.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie003.jpg","type":"GRAPHIC","id":"NTFILEDGnVqpGtTafaGDmP","market":"us","size":154400},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie004.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie004.jpg","type":"GRAPHIC","id":"NTFILE8nx15yNqNJPRjGRT","market":"us","size":115611},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie005.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie005.jpg","type":"GRAPHIC","id":"NTFILEFX8doJKB9iwTUdCA","market":"us","size":35257},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie006.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie006.jpg","type":"GRAPHIC","id":"NTFILE6CmpJBeQ6yKqjKDM","market":"us","size":104701},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie007.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie007.jpg","type":"GRAPHIC","id":"NTFILEHSQFbi63tbLzz452","market":"us","size":56893},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie008.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie008.jpg","type":"GRAPHIC","id":"NTFILED8xwe2TrfsRk2xu6","market":"us","size":123069},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie009.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie009.jpg","type":"GRAPHIC","id":"NTFILE5YBZNBFjTF7DhMbn","market":"us","size":44040},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie010.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie010.jpg","type":"GRAPHIC","id":"NTFILE5Di4Fi7kiiiGHD7j","market":"us","size":136678},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie011.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie011.jpg","type":"GRAPHIC","id":"NTFILE9RhwotiqPdN3uGcZ","market":"us","size":94515},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie012.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie012.jpg","type":"GRAPHIC","id":"NTFILEFi2uzEmA331DZP6q","market":"us","size":113131},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie013.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie013.jpg","type":"GRAPHIC","id":"NTFILE4x5tEvzvb8i2ac8J","market":"us","size":116345},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie014.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie014.jpg","type":"GRAPHIC","id":"NTFILEAdzCRSb55kmQGJZY","market":"us","size":113166},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie015.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie015.jpg","type":"GRAPHIC","id":"NTFILEDwS3e2tZSpGJTPrG","market":"us","size":129340},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie016.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie016.jpg","type":"GRAPHIC","id":"NTFILE7qnGzehZzb7VJH8p","market":"us","size":122471},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie017.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie017.jpg","type":"GRAPHIC","id":"NTFILEBwAcCm4rtzJXSHgK","market":"us","size":134341},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie018.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie018.jpg","type":"GRAPHIC","id":"NTFILEm5FhHtwTWkgDxVqH","market":"us","size":105650},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie019.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie019.jpg","type":"GRAPHIC","id":"NTFILED3ik11yWqzy1GPrJ","market":"us","size":126175},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie020.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie020.jpg","type":"GRAPHIC","id":"NTFILE9c8YfARk5rQdJNMA","market":"us","size":54838},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie021.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie021.jpg","type":"GRAPHIC","id":"NTFILE4C7N643ZESdPN1Mt","market":"us","size":95911},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie022.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie022.jpg","type":"GRAPHIC","id":"NTFILEBTGD7SsM52WQsMRk","market":"us","size":108550},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie023.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie023.jpg","type":"GRAPHIC","id":"NTFILEEmzMyZNjxC8S6tLp","market":"us","size":109002},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie024.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie024.jpg","type":"GRAPHIC","id":"NTFILEBxy4VCn7nisLj6H9","market":"us","size":117477},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie025.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie025.jpg","type":"GRAPHIC","id":"NTFILE9uf9tVXfniyA3PHU","market":"us","size":47883},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie026.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie026.jpg","type":"GRAPHIC","id":"NTFILE24UQ34grB8Sbj2YD","market":"us","size":142275},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie027.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie027.jpg","type":"GRAPHIC","id":"NTFILE3m9oPtYrfekZo6GN","market":"us","size":121351},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000090/phasebiocorporateovervie028.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie028.jpg","type":"GRAPHIC","id":"NTFILE3BnauGthH1WCNNVF","market":"us","size":57106}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-11-12 00:00","pubTimestamp":1605110400,"title_zh":"8-K  - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10576231","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000086-PHAS","pdf_url":null,"pub_time":1603382400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000086/0001169245-20-000086-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000086/ex991-pemziviptadilupd.htm","primary":true,"translateUrl":null,"linkName":"ex991-pemziviptadilupd.htm","type":"EX-99.1","id":"NTFILEHspS2bgQKMRwZumC","market":"us","size":17574},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000086/a8-kxpemziviptadilupda.htm","primary":false,"translateUrl":null,"linkName":"a8-kxpemziviptadilupda.htm","type":"8-K","id":"NTFILEFNk7FbESPw1oo18h","market":"us","size":31911},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000086/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILE96jKSeQ3oAk56t5K","market":"us","size":27705}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-10-23 00:00","pubTimestamp":1603382400,"title_zh":"8-K  - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10434102","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000083-PHAS","pdf_url":null,"pub_time":1601913600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000083/0001169245-20-000083-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000083/ex991-canadapatient.htm","primary":true,"translateUrl":null,"linkName":"ex991-canadapatient.htm","type":"EX-99.1","id":"NTFILEDGKuUKXA4Z2wbfYR","market":"us","size":25980},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000083/a8-kxcanadapatient.htm","primary":false,"translateUrl":null,"linkName":"a8-kxcanadapatient.htm","type":"8-K","id":"NTFILEEvWNXTmSjX96XtNp","market":"us","size":32253},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000083/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILEFTpWoRPxFyv6nDZd","market":"us","size":27705},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000083/reverseitlogo1.jpg","primary":false,"translateUrl":null,"linkName":"reverseitlogo1.jpg","type":"GRAPHIC","id":"NTFILE2av7Rz4qZWjcDsMG","market":"us","size":45254}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-10-06 00:00","pubTimestamp":1601913600,"title_zh":"8-K  - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10248373","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000075-PHAS","pdf_url":null,"pub_time":1597075200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"PHAS","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/0001169245-20-000075-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630.htm","primary":true,"translateUrl":null,"linkName":"phas-20200630.htm","type":"10-Q","id":"NTFILE8tDZ9xeNT9TdPt2U","market":"us","size":1822499},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/ex311-phas10xq2020q2.htm","primary":false,"translateUrl":null,"linkName":"ex311-phas10xq2020q2.htm","type":"EX-31.1","id":"NTFILE7kj2WegM5q2tQLAf","market":"us","size":12185},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/ex312-phas10xq2020q2.htm","primary":false,"translateUrl":null,"linkName":"ex312-phas10xq2020q2.htm","type":"EX-31.2","id":"NTFILE7dLSwwxTA327p7UR","market":"us","size":12176},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/ex-321xphas10xq2020q2.htm","primary":false,"translateUrl":null,"linkName":"ex-321xphas10xq2020q2.htm","type":"EX-32.1","id":"NTFILE5tHSDsARfRCUzKz5","market":"us","size":5950},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/ex-322xphas10xq2020q2.htm","primary":false,"translateUrl":null,"linkName":"ex-322xphas10xq2020q2.htm","type":"EX-32.2","id":"NTFILEGbLLKaprhiznXoUR","market":"us","size":5944},{"description":"XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630.xsd","primary":false,"translateUrl":null,"linkName":"phas-20200630.xsd","type":"EX-101.SCH","id":"NTFILEB2XXgPVpjMWodZ5d","market":"us","size":43389},{"description":"XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630_cal.xml","primary":false,"translateUrl":null,"linkName":"phas-20200630_cal.xml","type":"EX-101.CAL","id":"NTFILERZVD9rmc2HfsAfMY","market":"us","size":65095},{"description":"XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630_def.xml","primary":false,"translateUrl":null,"linkName":"phas-20200630_def.xml","type":"EX-101.DEF","id":"NTFILE3QCK5D71KPpkA7XS","market":"us","size":204199},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630_lab.xml","primary":false,"translateUrl":null,"linkName":"phas-20200630_lab.xml","type":"EX-101.LAB","id":"NTFILEC3jiRuJwV8a9HSxZ","market":"us","size":501664},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630_pre.xml","primary":false,"translateUrl":null,"linkName":"phas-20200630_pre.xml","type":"EX-101.PRE","id":"NTFILEFkBr3knno5H6DSVv","market":"us","size":317628},{"description":"EXTRACTED XBRL INSTANCE DOCUMENT","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/phas-20200630_htm.xml","primary":false,"translateUrl":null,"linkName":"phas-20200630_htm.xml","type":"XML","id":"NTFILEF2NaqWkNgmzrfMJm","market":"us","size":756257}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[{"id":29354,"name":"CONDENSED BALANCE SHEETS","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":29355,"name":"CONDENSED BALANCE SHEETS (Parenthetical)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":29356,"name":"CONDENSED STATEMENTS OF OPERATIONS","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":29357,"name":"CONDENSED STATEMENTS OF STOCKHOLDERS??? EQUITY","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":29358,"name":"CONDENSED STATEMENTS OF CASH FLOWS","name_zh":"简明现金流量表","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000075/R6.htm","cdn_url":"https://static.tigerbbs.com/a2aa5fce2b85117351b19d451f5972ac","translation_url":"https://static.tigerbbs.com/6f979bbab3712467af33b9febcf2df00","translate_status":1}],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2020-08-11 00:00","pubTimestamp":1597075200,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10248112","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000073-PHAS","pdf_url":null,"pub_time":1597075200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/0001169245-20-000073-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/ex991-earningsreleaseq.htm","primary":true,"translateUrl":null,"linkName":"ex991-earningsreleaseq.htm","type":"EX-99.1","id":"NTFILE9h1Mgkm3t52mx8ny","market":"us","size":116414},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/a8-kxearningsreleaseq2.htm","primary":false,"translateUrl":null,"linkName":"a8-kxearningsreleaseq2.htm","type":"8-K","id":"NTFILEBjJWjfktq7EPcVA5","market":"us","size":36660},{"description":"EX-99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie.htm","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie.htm","type":"EX-99.2","id":"NTFILE7557RcTMbyCuqA2C","market":"us","size":57677},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebio2020logo11.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo11.jpg","type":"GRAPHIC","id":"NTFILEEJE2Xo4eZoisyGAT","market":"us","size":27705},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie001.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie001.jpg","type":"GRAPHIC","id":"NTFILE9x64VAZpVKCqSQeV","market":"us","size":64627},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie002.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie002.jpg","type":"GRAPHIC","id":"NTFILE331DtApQLcdQudbo","market":"us","size":201139},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie003.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie003.jpg","type":"GRAPHIC","id":"NTFILEEveBLCaJyjgjh1cG","market":"us","size":164438},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie004.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie004.jpg","type":"GRAPHIC","id":"NTFILE4ufHaxpwwYvGf6DN","market":"us","size":131896},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie005.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie005.jpg","type":"GRAPHIC","id":"NTFILE8qqxCJHGZ4iXCynG","market":"us","size":35257},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie006.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie006.jpg","type":"GRAPHIC","id":"NTFILEBdZTTeMb42XrcxUM","market":"us","size":101121},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie007.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie007.jpg","type":"GRAPHIC","id":"NTFILE4HGUT1kdpKz9Hfqm","market":"us","size":57345},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie008.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie008.jpg","type":"GRAPHIC","id":"NTFILE97rDeVdpSHUWvzJD","market":"us","size":121494},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie009.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie009.jpg","type":"GRAPHIC","id":"NTFILEG2KeQFFdZGKvfyw2","market":"us","size":41144},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie010.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie010.jpg","type":"GRAPHIC","id":"NTFILE9SNjtm79mEmC4d1J","market":"us","size":136766},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie011.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie011.jpg","type":"GRAPHIC","id":"NTFILE8SFnC8GoxEauj9sf","market":"us","size":92725},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie012.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie012.jpg","type":"GRAPHIC","id":"NTFILEDjPdyH3AwYx1QZsX","market":"us","size":111164},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie013.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie013.jpg","type":"GRAPHIC","id":"NTFILEAK9BxRDt24qW7FBG","market":"us","size":116305},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie014.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie014.jpg","type":"GRAPHIC","id":"NTFILE7FHLk1CcNyCEpJEW","market":"us","size":113430},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie015.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie015.jpg","type":"GRAPHIC","id":"NTFILENtsRWS1eFUgmUw9q","market":"us","size":127092},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie016.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie016.jpg","type":"GRAPHIC","id":"NTFILE26yyeAV2Aievc5xa","market":"us","size":130463},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie017.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie017.jpg","type":"GRAPHIC","id":"NTFILEBeqyqFw4mNVNa8SD","market":"us","size":116773},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie018.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie018.jpg","type":"GRAPHIC","id":"NTFILEDPwRwfZmVbw9eNcx","market":"us","size":103589},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie019.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie019.jpg","type":"GRAPHIC","id":"NTFILE2BpP2KMbNeR2ibjw","market":"us","size":106923},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie020.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie020.jpg","type":"GRAPHIC","id":"NTFILE3Abj8cB9DzRmCeQE","market":"us","size":51127},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie021.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie021.jpg","type":"GRAPHIC","id":"NTFILE5n1KmTeAfvwETbP2","market":"us","size":95387},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie022.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie022.jpg","type":"GRAPHIC","id":"NTFILE5vvTfasRcDxAsvG4","market":"us","size":108385},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie023.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie023.jpg","type":"GRAPHIC","id":"NTFILEG9QK3n23KZ3SnMdo","market":"us","size":92956},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie024.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie024.jpg","type":"GRAPHIC","id":"NTFILEDq83e7pNc2dWKK14","market":"us","size":102063},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie025.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie025.jpg","type":"GRAPHIC","id":"NTFILE2xgp2hsYhPEnHPFM","market":"us","size":108807},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie026.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie026.jpg","type":"GRAPHIC","id":"NTFILE6NmPtvSPsUnifXFk","market":"us","size":137166},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie027.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie027.jpg","type":"GRAPHIC","id":"NTFILE5AeJRa2FLBy6DHwQ","market":"us","size":47883},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie028.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie028.jpg","type":"GRAPHIC","id":"NTFILE8LNapizisJrYeTtK","market":"us","size":142271},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie029.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie029.jpg","type":"GRAPHIC","id":"NTFILEHfvzNLxLig6S5eyC","market":"us","size":121365},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000073/phasebiocorporateovervie030.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie030.jpg","type":"GRAPHIC","id":"NTFILE8nbz7PzKuDanbLfR","market":"us","size":57106}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-08-11 00:00","pubTimestamp":1597075200,"title_zh":"8-K  - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10167445","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000071-PHAS","pdf_url":null,"pub_time":1594828800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000071/0001169245-20-000071-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000071/ex991-vangardpatient.htm","primary":true,"translateUrl":null,"linkName":"ex991-vangardpatient.htm","type":"EX-99.1","id":"NTFILE3G6HJqkuqtsZYVHo","market":"us","size":19166},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000071/a8-kxvangardpatient.htm","primary":false,"translateUrl":null,"linkName":"a8-kxvangardpatient.htm","type":"8-K","id":"NTFILE4QtQEiiq1rGrVxpc","market":"us","size":31383},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000071/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILE144GGZuPfbpTsaRd","market":"us","size":27705}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-07-16 00:00","pubTimestamp":1594828800,"title_zh":"8-K  - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9793002","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000055-PHAS","pdf_url":null,"pub_time":1591286400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000055/0001169245-20-000055-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000055/a8-kxvotingresults.htm","primary":true,"translateUrl":null,"linkName":"a8-kxvotingresults.htm","type":"8-K","id":"NTFILEHu1qhCs1Sadg25XT","market":"us","size":38706}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-06-05 00:00","pubTimestamp":1591286400,"title_zh":"8-K  - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9758437","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000053-PHAS","pdf_url":null,"pub_time":1590508800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000053/0001169245-20-000053-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000053/ex991-vangardstudy.htm","primary":true,"translateUrl":null,"linkName":"ex991-vangardstudy.htm","type":"EX-99.1","id":"NTFILE9whPifFvV8SGUrjS","market":"us","size":19367},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000053/a8-kxvangardstudy.htm","primary":false,"translateUrl":null,"linkName":"a8-kxvangardstudy.htm","type":"8-K","id":"NTFILEAKvrSYME6wueeEBg","market":"us","size":35401},{"description":"","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000053/phasebio2020logo1.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo1.jpg","type":"GRAPHIC","id":"NTFILE3Asv1pfg4eXw5FaP","market":"us","size":27705}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-05-27 00:00","pubTimestamp":1590508800,"title_zh":"8-K  - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9758441","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000049-PHAS","pdf_url":null,"pub_time":1589212800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"PHAS","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/0001169245-20-000049-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/ex991-earningsreleaseq12020.htm","primary":true,"translateUrl":null,"linkName":"ex991-earningsreleaseq12020.htm","type":"EX-99.1","id":"NTFILE9xQ7cADjGyexMnNe","market":"us","size":82467},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/a8-kxearningsreleaseq12020.htm","primary":false,"translateUrl":null,"linkName":"a8-kxearningsreleaseq12020.htm","type":"8-K","id":"NTFILE7u4qrcRU4bDN8dq8","market":"us","size":33474},{"description":"EXHIBIT 99.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie.htm","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie.htm","type":"EX-99.2","id":"NTFILECrh6gVUqrUPKAyPu","market":"us","size":51018},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebio2020logo.jpg","primary":false,"translateUrl":null,"linkName":"phasebio2020logo.jpg","type":"GRAPHIC","id":"NTFILEBp4T3ASc2XH7y71u","market":"us","size":27705},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie001.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie001.jpg","type":"GRAPHIC","id":"NTFILEAfjFGr7gVu9mX74q","market":"us","size":64307},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie002.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie002.jpg","type":"GRAPHIC","id":"NTFILEh8tgTzZPCJGzwt7F","market":"us","size":201861},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie003.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie003.jpg","type":"GRAPHIC","id":"NTFILE6t1843nGMhX9ycCt","market":"us","size":150094},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie004.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie004.jpg","type":"GRAPHIC","id":"NTFILE8tTSJWDxXBpkADQ7","market":"us","size":112508},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie005.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie005.jpg","type":"GRAPHIC","id":"NTFILEJ7yfjCzVZDAvtico","market":"us","size":35955},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie006.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie006.jpg","type":"GRAPHIC","id":"NTFILEozRpeCHKBg7z2uGy","market":"us","size":93739},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie007.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie007.jpg","type":"GRAPHIC","id":"NTFILEC2CP3DAqwy9vY7oC","market":"us","size":56859},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie008.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie008.jpg","type":"GRAPHIC","id":"NTFILECh7koGEB79tj9kNM","market":"us","size":122193},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie009.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie009.jpg","type":"GRAPHIC","id":"NTFILEG5dh2aoqPau7LUmq","market":"us","size":41847},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie010.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie010.jpg","type":"GRAPHIC","id":"NTFILE5djgu5jvVCRVtEq9","market":"us","size":136582},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie011.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie011.jpg","type":"GRAPHIC","id":"NTFILE7riw8zexu929Zz3m","market":"us","size":93420},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie012.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie012.jpg","type":"GRAPHIC","id":"NTFILEDhxN67343vTZS1VV","market":"us","size":108779},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie013.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie013.jpg","type":"GRAPHIC","id":"NTFILEu2BndLvh7MnYZSeM","market":"us","size":116318},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie014.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie014.jpg","type":"GRAPHIC","id":"NTFILEQc4c2FzvyjMRDPCe","market":"us","size":113515},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie015.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie015.jpg","type":"GRAPHIC","id":"NTFILE2HsEM5Q1ceVV1mo4","market":"us","size":126844},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie016.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie016.jpg","type":"GRAPHIC","id":"NTFILEFZjKm1S9Sj1A81bU","market":"us","size":129694},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie017.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie017.jpg","type":"GRAPHIC","id":"NTFILECi7dtERfmoHZeKc2","market":"us","size":116813},{"description":"","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie018.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie018.jpg","type":"GRAPHIC","id":"NTFILEA4Qg7qJ44w6YvtmY","market":"us","size":104010},{"description":"","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie019.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie019.jpg","type":"GRAPHIC","id":"NTFILE8hrMPVJU1gDXMpDJ","market":"us","size":107151},{"description":"","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie020.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie020.jpg","type":"GRAPHIC","id":"NTFILE9RTUjGC3fGHQeTzi","market":"us","size":55811},{"description":"","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie021.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie021.jpg","type":"GRAPHIC","id":"NTFILEFWdZUB3i2qUJ9fis","market":"us","size":109664},{"description":"","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie022.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie022.jpg","type":"GRAPHIC","id":"NTFILE8J65Py16naPyW9yM","market":"us","size":94588},{"description":"","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie023.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie023.jpg","type":"GRAPHIC","id":"NTFILEF5fboZuH1HNaFYPL","market":"us","size":109059},{"description":"","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie024.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie024.jpg","type":"GRAPHIC","id":"NTFILEFnfWjEgP7PMbsCQZ","market":"us","size":132651},{"description":"","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie025.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie025.jpg","type":"GRAPHIC","id":"NTFILE2xPDBH4YFwMg4p9A","market":"us","size":47883},{"description":"","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie026.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie026.jpg","type":"GRAPHIC","id":"NTFILE7B7wQKrYYGBYwy4L","market":"us","size":144237},{"description":"","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie027.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie027.jpg","type":"GRAPHIC","id":"NTFILE8LhzVy8VN4Tbs7iD","market":"us","size":122050},{"description":"","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000049/phasebiocorporateovervie028.jpg","primary":false,"translateUrl":null,"linkName":"phasebiocorporateovervie028.jpg","type":"GRAPHIC","id":"NTFILEDifpYYQseGo7v5DY","market":"us","size":57106}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-05-12 00:00","pubTimestamp":1589212800,"title_zh":"8-K  - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9758440","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000051-PHAS","pdf_url":null,"pub_time":1589212800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"PHAS","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/0001169245-20-000051-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/a10-q2020q1.htm","primary":true,"translateUrl":null,"linkName":"a10-q2020q1.htm","type":"10-Q","id":"NTFILE9ceRBkkeWC9kjFJY","market":"us","size":1147527},{"description":"EXHIBIT 31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/ex311-phas10xq2020q1.htm","primary":false,"translateUrl":null,"linkName":"ex311-phas10xq2020q1.htm","type":"EX-31.1","id":"NTFILEGjrfUuKypUxxX7Cr","market":"us","size":12746},{"description":"EXHIBIT 31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/ex312-phas10xq2020q1.htm","primary":false,"translateUrl":null,"linkName":"ex312-phas10xq2020q1.htm","type":"EX-31.2","id":"NTFILEH2bUxTdTA3cy1xW9","market":"us","size":12680},{"description":"EXHIBIT 32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/ex-321xphas10xq2020q1.htm","primary":false,"translateUrl":null,"linkName":"ex-321xphas10xq2020q1.htm","type":"EX-32.1","id":"NTFILEAqAqfEABnv5S8TeQ","market":"us","size":5796},{"description":"EXHIBIT 32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/ex-322xphas10xq2020q1.htm","primary":false,"translateUrl":null,"linkName":"ex-322xphas10xq2020q1.htm","type":"EX-32.2","id":"NTFILEBUTPkTrBsQiXVHfn","market":"us","size":5786},{"description":"XBRL INSTANCE DOCUMENT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/phas-20200331.xml","primary":false,"translateUrl":null,"linkName":"phas-20200331.xml","type":"EX-101.INS","id":"NTFILEHGUxdfHwmuWA72sN","market":"us","size":546155},{"description":"XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/phas-20200331.xsd","primary":false,"translateUrl":null,"linkName":"phas-20200331.xsd","type":"EX-101.SCH","id":"NTFILEAEZTV5DjoUfCanBa","market":"us","size":42859},{"description":"XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/phas-20200331_cal.xml","primary":false,"translateUrl":null,"linkName":"phas-20200331_cal.xml","type":"EX-101.CAL","id":"NTFILE7rkmey5yZnhKYDKt","market":"us","size":62314},{"description":"XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/phas-20200331_def.xml","primary":false,"translateUrl":null,"linkName":"phas-20200331_def.xml","type":"EX-101.DEF","id":"NTFILEEuc4nCsziEhzAQL3","market":"us","size":166536},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/phas-20200331_lab.xml","primary":false,"translateUrl":null,"linkName":"phas-20200331_lab.xml","type":"EX-101.LAB","id":"NTFILE8aD2WMiuQF7QCsEg","market":"us","size":506987},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/phas-20200331_pre.xml","primary":false,"translateUrl":null,"linkName":"phas-20200331_pre.xml","type":"EX-101.PRE","id":"NTFILEGsxYTs75AqiLgepd","market":"us","size":287685}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[{"id":7864,"name":"CONDENSED BALANCE SHEETS (unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":7865,"name":"CONDENSED BALANCE SHEETS (Parenthetical) (unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":7866,"name":"CONDENSED STATEMENTS OF OPERATIONS (unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":7867,"name":"CONDENSED STATEMENTS OF STOCKHOLDERS??? EQUITY (unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":7868,"name":"CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000051/R6.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2020-05-12 00:00","pubTimestamp":1589212800,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9384652","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000044-PHAS","pdf_url":null,"pub_time":1585497600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Securities to be offered to employees in employee benefit plans","symbol":"PHAS","title":"Securities to be offered to employees in employee benefit plans","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000044/0001169245-20-000044-index.htm","us_notice_code":"Form S-8","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000044/s-82020.htm","primary":true,"translateUrl":null,"linkName":"s-82020.htm","type":"S-8","id":"NTFILE9c1ud2A2TEb7vKB3","market":"us","size":116457},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000044/ex51-sx82020.htm","primary":false,"translateUrl":null,"linkName":"ex51-sx82020.htm","type":"EX-5.1","id":"NTFILE8XH9tiZ956U4zgEY","market":"us","size":10094},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000044/ex231-sx82020.htm","primary":false,"translateUrl":null,"linkName":"ex231-sx82020.htm","type":"EX-23.1","id":"NTFILEBGB1cHwy4xzCrwvU","market":"us","size":2420},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000044/cooleylogov2.jpg","primary":false,"translateUrl":null,"linkName":"cooleylogov2.jpg","type":"GRAPHIC","id":"NTFILE4wkteEejxQrjayvC","market":"us","size":55818}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-03-30 00:00","pubTimestamp":1585497600,"title_zh":"Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9384250","market":"us","labels":[],"media":"sec.gov","original_id":"AN116924520000043-PHAS","pdf_url":null,"pub_time":1585497600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"PHAS","title":"Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/0001169245-20-000043-index.htm","us_notice_code":"Form 10-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/a10-k2019.htm","primary":true,"translateUrl":null,"linkName":"a10-k2019.htm","type":"10-K","id":"NTFILEGpN21vfg7GYKxjJL","market":"us","size":1786748},{"description":"EXHIBIT 4.10","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex410-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex410-10xk2019.htm","type":"EX-4.10","id":"NTFILEBgSDi6khamvvR3cg","market":"us","size":78627},{"description":"EXHIBIT 4.11","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex411-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex411-10xk2019.htm","type":"EX-4.11","id":"NTFILEFaWvAgMqjMAQfYs8","market":"us","size":28093},{"description":"EXHIBIT 10.13","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1013-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1013-10xk2019.htm","type":"EX-10.13","id":"NTFILE6nCzWUYcXJfecSUJ","market":"us","size":29892},{"description":"EXHIBIT 10.16","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1016-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1016-10xk2019.htm","type":"EX-10.16","id":"NTFILE6ciP1XRvUSxcjpHG","market":"us","size":88014},{"description":"EXHIBIT 10.17","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1017-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1017-10xk2019.htm","type":"EX-10.17","id":"NTFILEGQPsEitNT4ZP1uXM","market":"us","size":111175},{"description":"EXHIBIT 10.18","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1018-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1018-10xk2019.htm","type":"EX-10.18","id":"NTFILE5yH6KcSZ1Eefq5cK","market":"us","size":69060},{"description":"EXHIBIT 10.21","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1021-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1021-10xk2019.htm","type":"EX-10.21","id":"NTFILE3RTbpy7Hvepb7f1i","market":"us","size":624796},{"description":"EXHIBIT 10.22","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1022-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1022-10xk2019.htm","type":"EX-10.22","id":"NTFILE9YNmvFtobqAmCS6E","market":"us","size":58366},{"description":"EXHIBIT 10.23","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex1023-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex1023-10xk2019.htm","type":"EX-10.23","id":"NTFILE5HszNYVt3bJ6DFDy","market":"us","size":395775},{"description":"EXHIBIT 23.1","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex231-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex231-10xk2019.htm","type":"EX-23.1","id":"NTFILEDwxUMmcd1fG6bojc","market":"us","size":3102},{"description":"EXHIBIT 31.1","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex311-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex311-10xk2019.htm","type":"EX-31.1","id":"NTFILE4gCDZQkegcfgfp7j","market":"us","size":12614},{"description":"EXHIBIT 31.2","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex312-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex312-10xk2019.htm","type":"EX-31.2","id":"NTFILE5bTVaaictK2xazam","market":"us","size":12920},{"description":"EXHIBIT 32.1","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex321-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex321-10xk2019.htm","type":"EX-32.1","id":"NTFILECVr3odjHgoJsDWkY","market":"us","size":6526},{"description":"EXHIBIT 32.2","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/ex322-10xk2019.htm","primary":false,"translateUrl":null,"linkName":"ex322-10xk2019.htm","type":"EX-32.2","id":"NTFILEAiUogDc9ZHHmPamp","market":"us","size":6618},{"description":"XBRL INSTANCE DOCUMENT","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/phas-20191231.xml","primary":false,"translateUrl":null,"linkName":"phas-20191231.xml","type":"EX-101.INS","id":"NTFILEHK4JovASVnwohf3x","market":"us","size":939030},{"description":"XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/phas-20191231.xsd","primary":false,"translateUrl":null,"linkName":"phas-20191231.xsd","type":"EX-101.SCH","id":"NTFILE84GQK9waVvhDXk5b","market":"us","size":57472},{"description":"XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/phas-20191231_cal.xml","primary":false,"translateUrl":null,"linkName":"phas-20191231_cal.xml","type":"EX-101.CAL","id":"NTFILE6fjQwkUL41wxt7Z9","market":"us","size":82038},{"description":"XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/phas-20191231_def.xml","primary":false,"translateUrl":null,"linkName":"phas-20191231_def.xml","type":"EX-101.DEF","id":"NTFILEBrz4HWFWSUr9tMb6","market":"us","size":271971},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/phas-20191231_lab.xml","primary":false,"translateUrl":null,"linkName":"phas-20191231_lab.xml","type":"EX-101.LAB","id":"NTFILE6orKVMGJJC7RRmhH","market":"us","size":772513},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/phas-20191231_pre.xml","primary":false,"translateUrl":null,"linkName":"phas-20191231_pre.xml","type":"EX-101.PRE","id":"NTFILEEzaPafcb14ZS9ntj","market":"us","size":427052},{"description":"","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/gssxylni2hvz000002a02.jpg","primary":false,"translateUrl":null,"linkName":"gssxylni2hvz000002a02.jpg","type":"GRAPHIC","id":"NTFILEmptyNYc6Rmbyz4JB","market":"us","size":34333},{"description":"","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/gssxylni2hvz000003a02.jpg","primary":false,"translateUrl":null,"linkName":"gssxylni2hvz000003a02.jpg","type":"GRAPHIC","id":"NTFILEAueYrcSDGJuyK251","market":"us","size":17114},{"description":"","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/gssxylni2hvz000004a02.jpg","primary":false,"translateUrl":null,"linkName":"gssxylni2hvz000004a02.jpg","type":"GRAPHIC","id":"NTFILEKfRAwri9bob3q3MG","market":"us","size":17544},{"description":"","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/gssxylni2hvz000005a02.jpg","primary":false,"translateUrl":null,"linkName":"gssxylni2hvz000005a02.jpg","type":"GRAPHIC","id":"NTFILE4cNh1wkoNwHxPycZ","market":"us","size":18940},{"description":"","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/gssxylni2hvz000006a02.jpg","primary":false,"translateUrl":null,"linkName":"gssxylni2hvz000006a02.jpg","type":"GRAPHIC","id":"NTFILEHb6pK1Qkj4xNDSyt","market":"us","size":31795},{"description":"","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000043/slide1a03.jpg","primary":false,"translateUrl":null,"linkName":"slide1a03.jpg","type":"GRAPHIC","id":"NTFILEF1XgedfVckvwWo7R","market":"us","size":133934}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2020-03-30 00:00","pubTimestamp":1585497600,"title_zh":"Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":113,"code":"91000000","status":"200"}]}}